FisherVista

Enterprise adoption of AI coding tools faces a cost crisis as Microsoft phases out Claude Code and Uber exhausts its 2026 AI budget within months, highlighting unsustainable expenses that could reshape industry strategies.

Frontieras North America Inc. is advancing its patented FASForm platform, a zero-waste process that converts coal into fuels, hydrogen, and industrial materials, positioning coal as a multi-output feedstock for modern energy and manufacturing markets.

Cardio Diagnostics Holdings will exhibit at four national benefits conferences in June to promote its AI-driven cardiovascular risk assessments, aiming to help employers and plan administrators reduce healthcare costs and improve outcomes.

Cardio Diagnostics Holdings will exhibit its AI-driven cardiovascular risk assessments at four national benefits conferences in June, aiming to help employers and plan administrators reduce healthcare costs and improve outcomes.

Numa Numa Resources Inc. is working to restart the historic Panguna Mine in Bougainville, aiming to transform its legacy of conflict into a model for sustainable development through community engagement and responsible governance.

Astrotech Corporation announced a strategic initiative focused on lunar resource development and future Moon-based manufacturing for quantum computing and semiconductors, leveraging NASA's Artemis program.

Yocale.ai Inc., an AI-powered operating system for beauty and wellness businesses, commenced trading on the Canadian Securities Exchange on May 7, 2026, marking a milestone in its mission to bring enterprise-level tools to independent service providers.

Trailbreaker Resources is set to drill three high-potential gold and copper targets in British Columbia in 2026, backed by a $3.5 million financing and full permits, marking a pivotal exploration phase.

NeuroOne Medical Technologies restates its March 31, 2026 quarterly results after a customer order modification led to a $0.5 million revenue overstatement, while the company reaffirms its fiscal year 2026 product revenue guidance of at least $10.5 million.

Helix BioPharma Corp. announced the grant of 1,297,000 incentive stock options at $1.63 per share and the cancellation of 2,200,000 options held by a director, reflecting ongoing equity compensation adjustments.

Virginia Governor Abigail Spanberger signed a package of 25 bills including cannabis resentencing reforms, impacting criminal justice, industry stakeholders, and legal markets.

President Trump's visit to China concluded with no major agreements on AI, Taiwan, or Iran, leaving key disputes unresolved and prompting companies like Core AI Holdings Inc. to assess the policy landscape.

Copper prices have surged above $14,000 per ton, approaching historic highs due to a global sulfur shortage, geopolitical tensions, and rising demand from AI and defense industries.

Rising health care costs are driving grassroots movements in Massachusetts to advocate for a single-payer system, which could influence national policy and impact insurers like Astiva Health.

Chinese automaker BYD is set to take over European factories from legacy automakers, signaling a major shift in the global EV industry and posing challenges for competitors like Massimo Group.

A federal jury in California sided with OpenAI CEO Sam Altman, ending a lawsuit from Elon Musk that centered on the founding purpose and future direction of OpenAI, highlighting tensions in the tech industry.

HeartBeam Inc. is developing a cable-free, high-fidelity ECG platform to address pre-hospital delays in cardiac care by enabling clinical-grade heart monitoring outside clinical settings.

LaFleur Minerals is advancing its Beacon Mill restart and Swanson Gold Project development, leveraging strategic acquisitions and strong gold prices to unlock value in the Abitibi gold belt.

Platinum's market fundamentals, including tightening supply and declining inventories, suggest the metal could see stronger price gains, supported by growing investment interest and demand from emerging technologies like artificial intelligence and hydrogen.

Regentis Biomaterials' GelrinC hydrogel implant, currently in a pivotal U.S. FDA trial with over 50% enrollment, could become the first approved off-the-shelf regenerative solution for knee cartilage defects, addressing a significant unmet need in the 472,500 annual arthroscopic knee procedures involving cartilage damage.